Dr Ronald A. DePinho

 

Dr. Ronald A. DePinho is a distinguished university professor and past president at MD Anderson Cancer Center. Ron is a global health leader, entrepreneur, physician and leading scientist in the fields of cancer and aging. In addition to his research, he has launched 3 biotech companies (Tvardi, Asylia, and Nirogy) focused on cancer, inflammation and fibrosis, with potential applications to COVID-19.

 
ronald_depinho.jpg
 
 
Contributions
Cancer Research and Investment Opportunities
Ronald A. DePinho
Cancer Research and Investment Opportunities
Ronald A. DePinho

Cancer exacts a steep social and economic toll, especially as an aging world population creates increased cancer rates. The investment community plays a critical role in supporting the conversion of entrepreneurial innovation into products and platforms that reduce the burden of cancer throughout the world.

Read More →
Ronald A. DePinho
 
Christian HodgsonRonald A. DePinho